In February 2022, these guidelines were reviewed by an expert work group convened by
ASH. Review included limited searches for new evidence and discussion of the search …

Background Heparin-induced thrombocytopenia (HIT) is an antibody-mediated adverse
drug reaction that can lead to devastating thromboembolic complications, including …

Thrombosis has long been recognized as a potentially lifethreatening complication in
children with congenital heart disease (CHD), children with acquired heart disease, and in …

This chapter about the recognition, treatment, and prevention of heparin-induced
thrombocytopenia (HIT) is part of the Antithrombotic and Thrombolytic Therapy: American …

Direct oral anticoagulants (DOACs) are attractive options for treatment of heparin-induced
thrombocytopenia (HIT). We report our continuing experience in Hamilton, ON, Canada …

A 63-year-old man with coronary artery disease who has recently undergone bypass
surgery presents with dyspnea. Laboratory testing reveals a platelet count of 86,000 per …

The article discusses a guideline for healthcare professionals in Great Britain on how to
manage bleeding in patients who are receiving antithrombotic drugs such as …

Heparin-induced thrombocytopenia is a prothrombotic adverse drug effect induced by
platelet-activating antibodies against multimolecular complexes of platelet factor 4 and …

Numerous acquired hemostatic abnormalities have been identified in renal insufficiency.
Hemodialysis procedures add to these disturbances as they repetitively imply turbulent …

Heparin-induced thrombocytopenia (HIT) is a clinicopathologic disorder that predisposes to
thrombosis. Diagnosis rests on a compatible clinical picture and laboratory evidence of …